|
|
||||||||
and CTGF have overlapping and distinct fibrogenic
effects on human renal cells
Divisions of 1 Rheumatology and Immunology and 3 Nephrology, 2 Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina 29425; and 4 Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami, Florida 33136
Transforming growth factor-
(TGF-
) and connective tissue growth factor (CTGF) are ubiquitously
expressed in various forms of tissue fibrosis, including fibrotic
diseases of the kidney. To clarify the common and divergent roles
of these growth factors in the cells responsible for pathological
extracellular matrix (ECM) deposition in renal fibrosis, the effects of
TGF-
and CTGF on ECM expression in primary human mesangial (HMCs)
and human proximal tubule epithelial cells (HTECs) were studied. Both
TGF-
and CTGF significantly induced collagen protein expression with similar potency in HMCs. Additionally,
2(I)-collagen
promoter activity and mRNA levels were similarly induced by TGF-
and
CTGF in HMCs. However, only TGF-
stimulated collagenous protein
synthesis in HTECs. HTEC expression of tenascin-C (TN-C) was increased
by TGF-
and CTGF, although TGF-
was the more potent inducer. Thus both growth factors elicit similar profibrogenic effects on ECM production in HMCs, while promoting divergent effects in HTECs. CTGF
induction of TN-C, a marker of epithelial-mesenchymal
transdifferentiation (EMT), with no significant induction of
collagenous protein synthesis in HTECs, may suggest a more predominant
role for CTGF in EMT rather than induction of excessive collagen
deposition by HTECs during renal fibrosis.
mesangial cells; tubule epithelial cells; collagen; tenascin; epithelial-mesenchymal transdifferentiation; connective tissue growth
factor; transforming growth factor-
This article has been cited by other articles:
![]() |
Y.-q. Xiao, K. Liu, J.-f. Shen, G.-T. Xu, and W. Ye SB-431542 Inhibition of Scar Formation after Filtration Surgery and Its Potential Mechanism Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1698 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Khawam, J. Giron-Michel, Y. Gu, A. Perier, M. Giuliani, A. Caignard, A. Devocelle, S. Ferrini, M. Fabbi, B. Charpentier, et al. Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor {alpha} Chain, Epithelial-to-Mesenchymal Transition Cancer Res., February 15, 2009; 69(4): 1561 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Bogatkevich, A. Ludwicka-Bradley, C. B. Singleton, J. R. Bethard, and R. M. Silver Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L603 - L611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, K. Devish, W. J. Langer, P. K. Carmines, and P. H. Lane Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1681 - F1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Burns, S. M. Twigg, J. M. Forbes, J. Pete, C. Tikellis, V. Thallas-Bonke, M. C. Thomas, M. E. Cooper, and P. Kantharidis Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product-Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2484 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roestenberg, F. A. van Nieuwenhoven, J. A. Joles, C. Trischberger, P. P. Martens, N. Oliver, J. Aten, J. W. Hoppener, and R. Goldschmeding Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1344 - F1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Lehti, M. Silvennoinen, R. Kivela, H. Kainulainen, and J. Komulainen Effects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscle Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E900 - E907. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qi, X. Chen, T. S. Polhill, S. Sumual, S. Twigg, R. E. Gilbert, and C. A. Pollock TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway Am J Physiol Renal Physiol, March 1, 2006; 290(3): F703 - F709. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuda, N. Fukuda, T. Ueno, Y. Tahira, H. Ayame, W. Zhang, T. Bando, H. Sugiyama, S. Saito, K. Matsumoto, et al. Development of Gene Silencing Pyrrole-Imidazole Polyamide Targeting the TGF-beta1 Promoter for Treatment of Progressive Renal Diseases J. Am. Soc. Nephrol., February 1, 2006; 17(2): 422 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Docherty, O. E. O'Sullivan, D. A. Healy, J. M. Fitzpatrick, and R. W. G. Watson Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction Am J Physiol Renal Physiol, January 1, 2006; 290(1): F4 - F13. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Almon, W. Lai, D. C. DuBois, and W. J. Jusko Corticosteroid-regulated genes in rat kidney: mining time series array data Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E870 - E882. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qi, S. Twigg, X. Chen, T. S. Polhill, P. Poronnik, R. E. Gilbert, and C. A. Pollock Integrated actions of transforming growth factor-{beta}1 and connective tissue growth factor in renal fibrosis Am J Physiol Renal Physiol, April 1, 2005; 288(4): F800 - F809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tan, B. Wang, J.-S. Keum, and A. A. Jaffa Mechanisms through which bradykinin promotes glomerular injury in diabetes Am J Physiol Renal Physiol, March 1, 2005; 288(3): F483 - F492. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention J. Am. Soc. Nephrol., January 1, 2004; 15(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Iwanciw, M. Rehm, M. Porst, and M. Goppelt-Struebe Induction of Connective Tissue Growth Factor by Angiotensin II: Integration of Signaling Pathways Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1782 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |